Cancer (Oncology)

Evergraf 0.25® Everolimus Tablets
Everolimus 0.25mg
- Composition
- Everolimus 0.25mg
- Dosage form
- Tablet
- Pack size
- Strip of 10 Tablet
- Manufacturer
- Mankind
- Also known as
- Afinitor, Zortress, Certican, Votubia
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Evergraf 0.25 mg contains everolimus, an immunosuppressant used to help prevent organ rejection following transplantation, particularly kidney or liver transplantation, according to the prescribed regimen. It works by reducing immune cell activity so the body is less likely to attack the transplanted organ
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
